1127-P: SGLT2 Inhibition (SGLT2i) Mediated Urinary Glucose Excretion (UGE) Associations with Metabolic and Renal Hemodynamic Parameters
Yuliya Lytvyn(University Health Network), Ele Ferrannini(Powertech Technology (Taiwan)), Bruce A. Perkins(Sinai Health System), Elza Muscelli, ANDRIY LYTVYN(Toronto General Hospital), David Cherney
Cited by 0
Related Papers
Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients
|Journal of Clinical Investigation|2014|1.1k
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations
|Diabetes Care|2016|969
Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension*
|Journal of Hypertension|2005|747
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure
|Circulation|2017|470